Early HPV Vaccine Implementation and Uptake in Five Nigerian States

Gbemisola T. Olubayo's study analyzes the early rollout of the Human Papillomavirus vaccine in Nigeria. The mixed-methods research includes quantitative data on vaccine availability and uptake across 52 facilities in five states over four months, supplemented by qualitative interviews with healthcare workers. The dataset was last updated on June 2, 2026, and is shared under a CC-BY-4.0 license.

Use Cases

• Analyzing geographic disparities in vaccine availability based on state-level data mentioned in the description
• Modeling factors influencing vaccine uptake based on qualitative themes like trust and sociocultural barriers
• Evaluating the relationship between facility preparedness and vaccine delivery outcomes
• Studying the evolution of community acceptance through narratives and peer influence as described

Strengths

• Includes data from 52 health facilities across five Nigerian states (Oyo, Jigawa, Kano, Lagos, Rivers)
• Combines quantitative metrics (e.g., 0-308 doses per facility over 4 months) with qualitative interview data
• Provides specific findings, such as 25% of facilities recording zero availability or uptake

Limitations

• The dataset is a 15.5 KB DOCX file, suggesting limited raw data or a summary document rather than a full structured dataset
• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment for quantitative analysis

Provenance

Source

Gbemisola T. Olubayo via figshare

Collection Method

Sequential explanatory mixed-methods design involving monthly facility visits, register reviews, and in-depth interviews with healthcare workers.

Time Range

Covers a 4-month period following Nigeria's 2023 HPV vaccine introduction; specific months not stated.

Freshness

Last updated 2026-06-02 15:40:17; freshness should be verified

Geography

Five Nigerian states: Oyo, Jigawa, Kano, Lagos, and Rivers.